Truist Securities Reiterates Hold on Treace Medical Concepts, Lowers Price Target to $4
Benzinga Newsdesk 11 months ago
NewsPrice TargetReiterationAnalyst Ratings
Truist Securities analyst Richard Newitter reiterates Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $7 to $4.
Truist Securities analyst Richard Newitter reiterates Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $7 to $4.